Llwytho...
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
BACKGROUND: We aimed to assess the efficacy and safety of erenumab, a fully human monoclonal antibody inhibiting the calcitonin gene-related peptide receptor (CGRPr), for the prevention of migraine in a real-life setting. MAIN BODY: We included in our observational study all patients with episodic o...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Headache Pain |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Milan
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7137484/ https://ncbi.nlm.nih.gov/pubmed/32264820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-020-01102-9 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|